Weight loss is sold as a simple equation: eat less, move more. But anyone who has tried to lose weight knows it is rarely ...
Amylyx Pharmaceuticals (NASDAQ:AMLX) executives told investors the company entered 2026 with a focus on advancing avexitide toward what could become the first FDA-approved therapy for post-bariatric ...
David Rosenbaum, Ph.D., joins as Chief Development OfficerChristo Shalish joins as Chief Business OfficerBOSTON--(BUSINESS WIRE)--Syntis Bio, Inc. a clinical-stage biopharmaceutical company advancing ...
The former TOWIE star, 44, showed off her sleek and shortened hairstyle in a stunning selfie after previously boasting long locks that tumbled down her shoulders.
Dr Arun Sharma India is facing a silent but rapidly growing epidemic – obesity and lifestyle-related diseases. Once ...
Analyst questions highlighted market validation, payer acceptance, and trial design robustness as ongoing concerns.
Many people don't realize that lifestyle choices have a bigger impact on weight than they think. Stress, sleep, and time ...
“For individuals with significant biological resistance to weight loss, modern obesity care now includes medically supervised weight management programmes, prescription therapies and, in selected ...
Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety ...
Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication.Phase 1 clinical trial of the patent-pending, rapid-onset formulation ...
Background Gastric outlet obstruction syndrome (GOOS) is a clinically significant condition often associated with advanced malignancies, particularly gastric and pancreatic cancers. Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results